Franklin Resources Inc. Grows Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Franklin Resources Inc. grew its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,300,240 shares of the company's stock after purchasing an additional 28,480 shares during the period. Franklin Resources Inc. owned about 1.08% of Privia Health Group worth $23,092,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new position in Privia Health Group in the second quarter worth $26,000. Nisa Investment Advisors LLC boosted its holdings in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock worth $31,000 after buying an additional 930 shares during the last quarter. GAMMA Investing LLC grew its position in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock valued at $31,000 after buying an additional 845 shares during the period. Signaturefd LLC increased its holdings in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock worth $34,000 after buying an additional 626 shares during the last quarter. Finally, Quarry LP raised its position in Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after acquiring an additional 2,533 shares during the period. 94.48% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PRVA has been the subject of a number of research reports. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, November 29th. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a report on Friday, November 8th. KeyCorp began coverage on Privia Health Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $23.00 target price on the stock. Macquarie initiated coverage on Privia Health Group in a research report on Monday. They set an "outperform" rating and a $25.00 price target on the stock. Finally, Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $24.80.

Privia Health Group Price Performance

NASDAQ:PRVA traded down $0.06 during trading hours on Friday, hitting $20.07. The stock had a trading volume of 2,385,376 shares, compared to its average volume of 843,271. The company has a 50 day simple moving average of $20.25 and a two-hundred day simple moving average of $19.11. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of 200.72, a P/E/G ratio of 5.45 and a beta of 0.83. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.